Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
📰 News Media
- 🏛️ [National] SAMHSA implements new harm reduction restrictions in updated guidance - naco.org
- 🩹 [Burlington, VT] Vermont Cares to take over Burlington needle exchange, move site to Bank Street - wcax.com
- 🏥 [Philadelphia, PA] For people in addiction, Project HOME's new facility bridges the gap between hospitalization and permanent housing - phillyvoice.com
- 💊 [National] SAMHSA Pubs Surprisingly Harm Reduction-y Guide for Pharmacists Prescribing Bupe - filtermag.org
- 💉 [National] How State Medicaid Uncertainties Are Reshaping the SUD Treatment Environment - bhbusiness.com
🗣️ Social Pulse
Lived/Living Experience
Innovation
- 🧰 Strips only show if fentanyl is present (mixed in with other substances like cocaine) they do not measure the concentration, purity, or safety. - Using a fentanyl test strip to prevent overdose can be the difference... - @secretoddities on X
- 🧪 Quick & easy analysis methods for drugs of abuse are in demand from health practitioners & law enforcement. In this app note, a method for fentanyl screening in urine is introduced, using the Touch Express™ Open... - @AdvionInterchim on X
Opposition Views
🏙 City Updates
- 💉 - [Chicago, IL] - June 24, 2026 - Cook County/Chicago Joint Opioid Report Shows Third Year of Decline in Opioid Overdose Deaths - chicago.gov
📧 - [Philadelphia, PA] - June 23, 2026 - PDPH Update - Emerging Practices for Managing Medetomidine Withdrawal in the Outpatient Setting - newsletter
EXCERPT: "- The Philadelphia Department of Public Health released a Health Update on emerging practices for managing medetomidine withdrawal in the outpatient setting.
- At hospital discharge, clonidine should be limited to a maximum outpatient dose of 0.3 mg three times daily, with follow-up within 2-5 days and initial weekly clinic visits to monitor blood pressure and taper.
- The update notes that medetomidine is nearly always detected with fentanyl, underscoring the need to address co-occurring opioid withdrawal and consider appropriate induction strategies.
- The update describes two outpatient management strategies for co-occurring medetomidine and opioid withdrawal: a co-management approach with gradual methadone or buprenorphine induction and a sequential approach with rapid buprenorphine stabilization followed by alpha-2-agonist management.
- Clinicians are advised to monitor blood pressure regularly, discuss current drug use non-judgmentally, and consider inpatient admission for very elevated blood pressure or inability to tolerate medications by mouth."
🔗 Click to sign up for the Philadelphia, PA newsletter.
📚 Academic Research
- 💉 Integrated Governance of the Synthetic Opioid Crisis: A Comparative Review From a Public Health Perspective in the United States and China - Current Addiction Reports - 2026-06-23 - doi.org
- 🚐 “How are we going to be able to pull that off?”: staff perspectives on the early implementation of mobile medication units in New York State - Addiction Science & Clinical Practice - 2026-06-24 - doi.org
- 💊 Pilot evaluation of a pharmacist-led technical assistance program to address buprenorphine dispensing in community pharmacies - Exploratory Research in Clinical and Social Pharmacy - 2026-06-19 - doi.org
⚖️ Law & Policy
Federal Agencies
- ⚖️ [United States] [Final Rule] Schedules of Controlled Substances: Temporary Placement of O-Desmethyltramadol in Schedule I - federalregister.gov
- ⚖️ [United States] [Final Rule] Schedules of Controlled Substances: Placement of Bromazolam in Schedule I; Correction - federalregister.gov
State Laws
- 📜 [Arizona] substance use disorder treatment; committee - openstates.org
- 📜 [Rhode Island] AN ACT RELATING TO FOOD AND DRUGS -- UNIFORM CONTROLLED SUBSTANCES ACT - openstates.org
City Ordinances
💸 Funding
Current
- 💸 Health Resources and Services Administration - Rural Communities Opioid Response Program (RCORP)-Impact - Deadline: Jul 8, 2026
- 💸 Health Resources and Services Administration - Rural Communities Opioid Response Program (RCORP)-Planning - Deadline: Jul 8, 2026
- 💸 Substance Abuse and Mental Health Services Adminis - Preventing Youth Overdose: Treatment, Recovery, Education, Awareness and Training - Deadline: Jul 16, 2026
- 💸 Substance Abuse and Mental Health Services Adminis - Tribal Opioid Response - Deadline: Jul 16, 2026
- 💸 Health Resources and Services Administration - Screening & Treatment for Maternal Mental Health and Substance Use Disorders (MMHSUD) - Deadline: Jul 17, 2026
- 💸 National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- 🏥 Hearst Foundations - Health - Hearst Foundations - Year-round, rolling grant applications (Health applicants) - Minimum grant size is $100,000. - Deadline: Year-round, rolling applications; there are no deadlines.
- 🤝 Hearst Foundations - Social Service - Hearst Foundations – Social Service (year-round rolling grant applications) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- 🧡 Smart Family Fund - First time grants ranging from $25,000 to $100,000. - Deadline: Open pitch